Mantrust Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-07-2024
- Paid Up Capital ₹ 1.00 M
as on 25-07-2024
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.94 M
as on 25-07-2024
- Revenue 88.79%
(FY 2023)
- Profit 34.03%
(FY 2023)
- Ebitda 124.40%
(FY 2023)
- Net Worth 6.19%
(FY 2023)
- Total Assets -0.61%
(FY 2023)
About Mantrust Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹0.94 M.
Manish Singh and Rajani serve as directors at the Company.
- CIN/LLPIN
U74999UR2017PTC008243
- Company No.
008243
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mantrust Pharma Private Limited offer?
Mantrust Pharma Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Health Supplement, Herbal Juice, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Common Disease Medicines, Pharmaceutical Capsules, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Ayurvedic Powder and Medicinal Herbs, Herbal Powder.
Who are the key members and board of directors at Mantrust Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Singh  | Director | 10-Nov-2017 | Current |
| Rajani | Director | 11-Dec-2019 | Current |
Financial Performance of Mantrust Pharma.
Mantrust Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 88.79% increase. The company also saw a substantial improvement in profitability, with a 34.03% increase in profit. The company's net worth moved up by a moderate rise of 6.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mantrust Pharma?
In 2023, Mantrust Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mirthlife Healthcare Private LimitedActive 8 years 8 monthsManish Singh and Rajani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Nov 2021 | ₹0.94 M | Open |
How Many Employees Work at Mantrust Pharma?
Unlock and access historical data on people associated with Mantrust Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mantrust Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mantrust Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
